| scholarly article | Q13442814 |
| P2093 | author name string | Paul A Fishman | |
| P2860 | cites work | Actual Causes of Death in the United States, 2000 | Q22253001 |
| Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis | Q24628826 | ||
| Variations in treatment benefits influence smoking cessation: results of a randomised controlled trial | Q28366170 | ||
| Medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in smoking prevalence | Q28473238 | ||
| Modeling the impact of smoking-cessation treatment policies on quit rates | Q33744313 | ||
| A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease | Q33775530 | ||
| Medical costs of smoking in the United States: estimates, their validity, and their implications | Q33795479 | ||
| Changes in smoking prevalence among U.S. adults by state and region: Estimates from the Tobacco Use Supplement to the Current Population Survey, 1992-2007 | Q33945878 | ||
| US public health service clinical practice guideline: treating tobacco use and dependence. | Q34072032 | ||
| State estimates of Medicaid expenditures attributable to cigarette smoking, fiscal year 1993 | Q34200539 | ||
| Evaluation of the economic impact of California's Tobacco Control Program: a dynamic model approach | Q34291319 | ||
| Cost of smoking to the Medicare program, 1993 | Q34326763 | ||
| The financial impact of smoking on health-related costs: a review of the literature | Q34335271 | ||
| Health care costs among smokers, former smokers, and never smokers in an HMO. | Q34335837 | ||
| Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research | Q34448161 | ||
| Addressing tobacco in managed care: results of the 2003 survey | Q35131302 | ||
| Quit attempt correlates among smokers by race/ethnicity | Q35534846 | ||
| Impact of smoking status on workplace absenteeism and productivity | Q35538108 | ||
| If smoking increases absences, does quitting reduce them? | Q35539334 | ||
| Short term effects of cigarette smoking on hospitalisation and associated lost workdays in a young healthy population | Q35540513 | ||
| Smoking cessation for the secondary prevention of coronary heart disease. | Q35570471 | ||
| Prevention of smoking-related deaths in the United States | Q35840315 | ||
| Increasing the demand for and use of effective smoking-cessation treatments reaping the full health benefits of tobacco-control science and policy gains--in our lifetime | Q37005329 | ||
| Disparities in health care utilization by smoking status--NHANES 1999-2004 | Q37167399 | ||
| Treating tobacco dependence in light of the 2008 US Department of Health and Human Services clinical practice guideline | Q37285568 | ||
| Secondary prevention strategies for coronary heart disease | Q37582800 | ||
| Prioritizing clinical preventive services: a review and framework with implications for community preventive services | Q37586416 | ||
| Best practices for smoking cessation: implications for employer-based programs | Q37596350 | ||
| Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes | Q38376003 | ||
| Poor mental health and smoking: interactive impact on wages. | Q40361822 | ||
| Risk groups and predictors of short-term abstinence from smoking in patients with coronary heart disease | Q42645639 | ||
| Changes in health care costs before and after smoking cessation | Q43774550 | ||
| Health plan implementation of U.S. Preventive Services Task Force A and B recommendations--Colorado, 2010. | Q43787278 | ||
| Does insurance coverage for drug therapy affect smoking cessation? | Q44114600 | ||
| Cigarette tax increase and media campaign cost of reducing smoking-related deaths | Q44546215 | ||
| Does a health plan effort to increase smokers' awareness of cessation medication coverage increase utilization and cessation? | Q44910528 | ||
| Medicaid coverage for tobacco-dependence treatments | Q46084082 | ||
| Trends in employer-sponsored health insurance coverage for tobacco-dependence treatments | Q46436163 | ||
| The importance of treating tobacco dependence | Q46526212 | ||
| 75 years of mortality in the United States, 1935-2010. | Q46575996 | ||
| Employer coverage of clinical preventive services in the United States | Q46900716 | ||
| Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. | Q50633808 | ||
| Relationship between tobacco control policies and the delivery of smoking cessation services in nonprofit HMOs. | Q50772578 | ||
| A smoking cessation intervention for head and neck cancer patients: trial design, patient accrual, and characteristics. | Q51156227 | ||
| Setting a challenging yet realistic smoking prevalence target for Healthy People 2020: learning from the California experience. | Q51976567 | ||
| Smoking status and risk for recurrent coronary events after myocardial infarction. | Q53665382 | ||
| Increasing Tobacco Cessation in America | Q56930804 | ||
| Inpatient smoking-cessation counseling and all-cause mortality in patients with acute myocardial infarction | Q57689046 | ||
| Tobacco control success versus demographic destiny: examining the causes of the low smoking prevalence in California | Q57941585 | ||
| Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000 | Q61192532 | ||
| Smoking cessation and absence from work | Q70794810 | ||
| The Impact of Smoking and Quitting on Health Care Use | Q72007326 | ||
| The physician-delivered smoking intervention project: can short-term interventions produce long-term effects for a general outpatient population? | Q72118856 | ||
| The role of tobacco intervention in population-based health care: a case study | Q74497997 | ||
| Physician smoking-cessation actions: are they dependent on insurance coverage or on patients? | Q78289139 | ||
| Knowledge of Medicaid coverage and effectiveness of smoking treatments | Q79258651 | ||
| Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease | Q79765395 | ||
| Smokers' attitudes and behaviors related to consumer demand for cessation counseling in the medical care setting | Q80206302 | ||
| Mortality from leading causes by education and race in the United States, 2001 | Q80207826 | ||
| Insurance coverage of smoking cessation treatment for state employees | Q80396218 | ||
| A clinical blueprint to accelerate the elimination of tobacco use | Q81226523 | ||
| Building consumer demand for tobacco-cessation products and services: The national tobacco cessation collaborative's consumer demand roundtable | Q82998502 | ||
| Medicare provides more coverage for smoking cessation | Q83106498 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 542-548 | |
| P577 | publication date | 2012-12-01 | |
| P1433 | published in | Journal of Cardiovascular Risk | Q27723050 |
| P1476 | title | Impact of Broadened Coverage of Smoking Cessation Treatments on Cardiovascular Disease | |
| P478 | volume | 6 |
| Q55437110 | Cardiometabolic risk in polycystic ovary syndrome. | cites work | P2860 |
Search more.